Long-Term Efficacy of Haloperidol in Autistic Children: Continuous versus Discontinuous Drug Administration

104Citations
Citations of this article
38Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The aim of this study was to evaluate the long-term efficacy of haloperidol in autistic children and to determine whether discontinuous drug administration was as effective as continuous drug administration. Sixty children, 48 males and 12 females, ages 2.3 to 7.9 years ( (Figure presented.) 5.1) completed the study. They received haloperidol over a period of 6 months followed by a 4-week drug withdrawal/placebo period. Haloperidol remained effective, and the discontinuous treatment schedule did not diminish its efficacy. Children with prominent symptoms of irritability, angry and labile affect, and uncooperativeness were the best responders to haloperidol. © 1989, The American Academy of Child and Adolescent Psychiatry. All rights reserved.

Cite

CITATION STYLE

APA

PERRY, R., CAMPBELL, M., ADAMS, P., LYNCH, N., SPENCER, E. K., CURREN, E. L., & OVERALL, J. E. (1989). Long-Term Efficacy of Haloperidol in Autistic Children: Continuous versus Discontinuous Drug Administration. Journal of the American Academy of Child and Adolescent Psychiatry, 28(1), 87–92. https://doi.org/10.1097/00004583-198901000-00016

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free